Crenezumab Biosimilar - Anti-APP Antibody - BSA and Azide free (A338743)

Crenezumab Biosimilar - Anti-APP Antibody - BSA and Azide free

Humanized monoclonal antibody to APP. Research grade Crenezumab biosimilar.

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Human

Humanized

Monoclonal

IgG4

Liquid

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

A4, ABPP, AD1, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta precursor protein, APPI